1-3 of 3
David M. Weiner
Close
Sort by
Journal Articles

Clinical Outcomes of Single-Agent Chemotherapy in a Diverse Cohort of Patients with Recalcitrant Cutaneous T-Cell Lymphoma

David M. Weiner, Andrew Ly, Sai Talluru, Richard F. Ambinder, Sima Rozati
Journal: Blood
Blood (2022) 140 (Supplement 1): 12046.
https://doi.org/10.1182/blood-2022-171218
Published: 2022
Journal Articles

Predictive Factors and Outcomes for Ibrutinib Therapy in Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter Cohort Study

Narendranath Epperla, MDMS, Qiuhong Zhao, MS, Sayan Mullick Chowdhury, PhD, Tamara K. Moyo, MD, Lauren Shea, MD, Nishitha Reddy, MD MSCI, Julia Sheets, MD, David M. Weiner, BA, Praveen Ramakrishnan Geethakumari, MD MS, Malathi Kandarpa, PhD, Ximena JordanBruno, MD, Colin Thomas, MD, Michael C. Churnetski, Andrew Hsu, MD, Joseph Maakaron, MD, Paolo Caimi, MD, Pallawi Torka, MD, Celeste Bello, MD, Cherie Tan, MD, Kevin A. David, MD, Kathryn Lindsey, MD, Irl Brian Greenwell, MD, Murali Janakiram, MD, Adam J Olszewski, MD, Jonathon B. Cohen, MDMS, Neil Palmisiano, MDMS, Elvira Umyarova, MD, Ryan A. Wilcox, MD, Farrukh T Awan, MD, Stefan K. Barta, MDMRCP,MS, Natalie S Grover, MD, Nancy L. Bartlett, MD, Yazeed Sawalha, MD, Beth A. Christian, MD, Alex F. Herrera, MD, Geoffrey Shouse, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-135870
Published: 2020
Journal Articles

Outcomes and Toxicities of Ibrutinib in Marginal Zone Lymphoma: A Retrospective Cohort Study at a Single Institution

David M. Weiner, BA, Nathaniel D. Robinson, MD, Steven M. Bair, MD, Hatcher J. Ballard, BS, Mitchell E. Hughes, PharmD, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, Stefan K. Barta, MD MRCP, MS, Elise A. Chong, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5250.
https://doi.org/10.1182/blood-2019-128556
Published: 2019